Intravenous calcitriol normalizes insulin sensitivity in uremic patients.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Kidney International

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/KI.1995.24PMID 7731147
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery

  2007cited by this paper
• Mathematical models of insulin secretion in physiological and clinical investigations.

  1994cited by this paper
• Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.

  1992cited by this paper
• Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients

  1992cited by this paper
• Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery

  1992cited by this paper
• Glucose and insulin metabolism in uremia.

  1992cited by this paper
• Effects of 1,25 (OH)2 D3 Treatment on Lipid Levels in Uremic Hemodialysis Patients

  1992cited by this paper
• Banting lecture 1990. Beta-cells in type II diabetes mellitus.

  1991cited by this paper
• The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.

  1991cited by this paper
• No major metabolic alterations accompany the hypotensive effect of active vitamin D.

  1991cited by this paper
• Glucose metabolism in non-diabetic and insulin-dependent diabetic subjects with end-stage renal failure.

  1991cited by this paper
• β-cells in type II diabetes mellitus

  1991cited by this paper
• Estimation of beta-cell secretion and insulin hepatic extraction by the minimal modelling technique.

  1990cited by this paper
• Direct effect of parathyroid hormone on insulin secretion from pancreatic islets.

  1990cited by this paper
• Effects on serum parathyroid hormone of intravenous treatment with alphacalcidol in patients on chronic hemodialysis.

  1990cited by this paper
• Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach

  1989cited by this paper
• Effects of physiologic and supraphysiologic hyperglycemia on early and late-phase insulin secretion in chronically dialyzed uremic patients.

  1989cited by this paper
• Insulin Secretion and Hepatic Extraction in Humans by Minimal Modeling of C-Peptide and Insulin Kinetics

  1988cited by this paper
• Insulin release from pancreatic islets: effects of CRF and excess PTH.

  1988influential reference
• Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.

  1987cited by this paper
• MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

  1986cited by this paper
• Role of parathyroid hormone in the glucose intolerance of chronic renal failure.

  1985cited by this paper
• Glucose metabolism and insulin sensitivity in patients on chronic hemodialysis.

  1985cited by this paper
• Importance of Glucose Per Se to Intravenous Glucose Tolerance: Comparison of the Minimal-Model Prediction with Direct Measurements

  1985cited by this paper
• The influence of hyperparathyroidism on glucose metabolism in uremia.

  1985influential reference
• Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas.

  1984cited by this paper
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

  1984cited by this paper
• Secondary hyperparathyroidism and glucose intolerance in children with uremia.

  1983cited by this paper
• Insulin resistance in uremia mediated by postbinding defects.

  1982cited by this paper
• Immunocytochemistry of vitamin D-dependent calcium binding protein in chick pancreas: exclusive localization.

  1982cited by this paper
• Lipid abnormalities in uremia, dialysis, and transplantation.

  1981cited by this paper
• Insulin resistance in uremia.

  1981cited by this paper
• Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.

  1981cited by this paper
• Lack of effect of parathyroid hormone on hepatic glucose metabolism in the dog.

  1981cited by this paper
• Studies on the mode of action of calciferol. XXIX. Biochemical characterization of 1,25-dihydroxyvitamin D3 receptors in chick pancreas and kidney cytosol.

  1981cited by this paper
• Vitamin D deficiency inhibits pancreatic secretion of insulin.

  1980cited by this paper
• Hyperlipoproteinemia in renal insufficiency.

  1980cited by this paper
• Quantitative Estimation of Beta Cell Sensitivity to Glucose in the Intact Organism: A Minimal Model of Insulin Kinetics in the Dog

  1980cited by this paper
• Quantitative estimation of insulin sensitivity.

  1979cited by this paper
• Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.

  1978cited by this paper
• Effect of acute uremia on insulin removal by the isolated perfused rat liver and muscle.

  1978cited by this paper

• Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease

  2022cites this paper
• Vitamin D Metabolites: Analytical Challenges and Clinical Relevance

  2022cites this paper
• Diabetes mellitus in dialysis and renal transplantation

  2021cites this paper
• Assessment of Insulin Resistance and its Correlation with 25-OH Vitamin D in Chronic Kidney Disease

  2020cites this paper
• Disturbances in Insulin-Glucose Metabolism in Patients with Advanced Renal Disease with and without Diabetes.

  2019influential citation
• Vitamin D Disorders in Chronic Kidney Disease

  2019cites this paper
• Managing hyperglycaemia in patients with diabetes and diabetic nephropathy–chronic kidney disease Summary of recommendations 2018

  2018cites this paper
• Carbohydrate Metabolism in Chronic Kidney Disease

  2018cites this paper
• Vitamin D receptor activation by paricalcitol and insulin resistance in CKD.

  2017cites this paper
• Vitamin D and insulin resistance

  2016cites this paper
• THE IMPACT OF DIABETES IN PROGRESS OF CHRONIC KIDNEY DISEASE

  2016cites this paper
• Effect of Insulin Resistance in Chronic Kidney Disease

  2016cites this paper
• CHRONIC KIDNEY DISEASE IN DIBETES

  2016cites this paper
• DIABETES AND INFLUENCE IN PROGRESS CHRONIC KIDNEY FAILURE

  2016cites this paper
• Insulin resistance as a therapeutic target for chronic kidney disease.

  2015cites this paper
• The impact of dialysis therapy on metabolic syndrome traits at the Groote Schuur Hospital

  2015cites this paper
• Hypoglycemia in Patients with Diabetes and Renal Disease

  2015cites this paper
• Use of Vitamin D Receptor Activator, Incident Cardiovascular Disease and Death in a Cohort of Hemodialysis Patients

  2015cites this paper
• Potential of vitamin D in treating diabetic cardiomyopathy.

  2015cites this paper
• Study of the effect of vitamin D supplementation on glycemic control in type 2 diabetic prevalent hemodialysis patients

  2015cites this paper
• Sarcopenia in chronic kidney disease.

  2015cites this paper
• The effects of short-term vitamin D supplementation on glucose metabolism in dialysis patients: a systematic review and meta-analysis

  2015cites this paper
• Uraemic sarcopenia: aetiology and implications.

  2014cites this paper
• Impact de l'insuffisance rénale chronique sur les transporteurs de glucose et les effets subséquents sur la résistance à l'insuline

  2014cites this paper
• Diabetes in Hyperparathyroidism

  2014cites this paper
• Full Reviews Uraemic sarcopenia: aetiology and implications

  2014cites this paper
• Hypoglycemia, chronic kidney disease, and diabetes mellitus.

  2014cites this paper
• direct and model-based measurements during OGTT Insulin and C-peptide secretion and kinetics in humans:

  2013cites this paper
• A Pilot Study of Active Vitamin D Administration and Insulin Resistance in African American Chronic Hemodialysis Patients

  2013cites this paper
• Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3–4: A randomized controlled trial

  2013cites this paper
• Shining light on vitamin D trials in chronic kidney disease.

  2013cites this paper
• A pilot study of active vitamin D administration and insulin resistance in African American patients undergoing chronic hemodialysis.

  2013cites this paper
• Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients

  2013cites this paper
• Carbohydrate Metabolism in Kidney Disease and Kidney Failure

  2013cites this paper
• Vitamin d: a strong cardiovascular connection

  2012cites this paper
• Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease

  2012cites this paper
• Basic endocrinological disorders in chronic renal failure.

  2012cites this paper
• Vitamin D supplementation in pre-dialysis chronic kidney disease

  2012cites this paper
• Effect of Activated Vitamin D on Glucoparameters in HCV Seropositive and Seronegative Patients on Chronic Hemodialysis

  2012cites this paper
• © 2012 Landes Bioscience. Do not distribute. Vitamin D supplementation in pre-dialysis chronic kidney disease A systematic review

  2012cites this paper
• Hypovitaminosis D and insulin resistance in peritoneal dialysis patients

  2011cites this paper
• Factors determining insulin resistance in chronic hemodialysis patients.

  2011cites this paper
• Vitamin D insufficiency and diabetes risks.

  2011cites this paper
• Shining D' light on chronic kidney disease: Mechanisms that may underpin the cardiovascular benefit of vitamin D

  2011cites this paper
• Measurement of insulin resistance in chronic kidney disease

  2011cites this paper
• Vitamin D Deficiency

  2010cites this paper
• Role of Vitamin D in Insulin Secretion and Insulin Sensitivity for Glucose Homeostasis

  2009cites this paper
• Management of diabetes in dialysis patients

  2009cites this paper
• Vitamin D levels and patient outcome in chronic kidney disease.

  2009cites this paper
• Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians.

  2009cites this paper
• Vitamin D therapy for chronic kidney disease.

  2009cites this paper
• The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with Chronic Kidney Disease: a randomised controlled trial

  2009cites this paper
• Role of vitamin D in chronic kidney disease.

  2009cites this paper
• [Insulin resistance and chronic kidney disease].

  2008influential citation
• Vitamin D, glucose, insulin, and insulin sensitivity.

  2008cites this paper
• Effect of Exogenous Intermittent Recombinant Human PTH 1–34 Administration and Chronic Endogenous Parathyroid Hormone Excess on Glucose Homeostasis and Insulin Sensitivity

  2008cites this paper
• Commentary

  2008cites this paper
• Commentary

  2008cites this paper
• EFFECTS OF CALCITRIOL (1,25(OH)2D3 TREATMENT ON CONTROL OF GLUCOSE INTOLERANCE IN HEMODIALYSIS PATIENTS

  2008cites this paper
• Parathyroid Hormone: Effects on Glucose Homeostasis and Insulin Sensitivity in Chronic Renal Failure Patients on Regular Hemodialysis “Arabic abstracts”

  2008cites this paper
• Impact of treatment with oral calcitriol on glucose intolerance and dyslipidemia(s) in hemodialysis patients.

  2008cites this paper
• Vitamin D, the renin-angiotensin system, and insulin resistance

  2008cites this paper
• What are the Clinically Important Consequences of ESRD‐Associated Endocrine Dysfunction?

  2008cites this paper
• Association of Insulin Resistance with de novo Coronary Stenosis after Percutaneous Coronary Artery Intervention in Hemodialysis Patients

  2008cites this paper
• Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure.

  2008cites this paper
• Vitamin D and glucose metabolism in chronic kidney disease

  2008cites this paper
• Relationship between vitamin D and muscle size and strength in patients on hemodialysis.

  2007cites this paper
• The Effect of Hepatitis C Virus Infection on Insulin Resistance in Chronic Haemodialysis Patients

  2007cites this paper
• Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron.

  2007cites this paper
• with a dominant-negative mutant hepatocyte nuclear factor-1{alpha} A novel approach to assess insulin sensitivity reveals no increased insulin sensitivity in mice

  2007cites this paper
• Evidence for Increased Risk of Prediabetes in the Uremic Patient

  2007cites this paper
• Metabolic Disturbances in Relation to Serum Calcium and Primary Hyperparathyroidism

  2006cites this paper
• Insulin resistance and renal disease.

  2006cites this paper
• The pleiotropic actions of vitamin D Mini-review

  2006cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 153 Metabolic Disturbances in Relation to Serum Calcium and Primary Hyperparathyroidism

  2006cites this paper
• PKC-mediated modulation of L-type calcium channels may contribute to fat-induced insulin resistance.

  2006cites this paper
• Carbohydrate metabolism in uraemia

  2005cites this paper
• Nutraceutical resources for diabetes prevention--an update.

  2005cites this paper
• Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-α-D3

  2005cites this paper
• Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.

  2005cites this paper
• The role of vitamin D in protecting type 1 diabetes mellitus

  2005cites this paper
• The Influence of Intravenous 1,25(OH)2D3 Therapy on Glucose Metabolism in Hemodialyzed Patients with Secondary Hyperparathyroidism

  2004cites this paper
• Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytes.

  2004cites this paper
• Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.

  2004cites this paper
• HEMODİYALİZ HASTALARINDA İNSÜLİN DİRENCİ ÜZERİNE PARATHORMONUN ETKİSİ THE EFFECT OF PARATHYROID HORMONE ON THE INSULIN RESISTANCE IN HEMODIALYSIS PATIENTS

  2004cites this paper
• Impaired Insulin sensitivity and Insulin secretion in Haemodialysis patients with and without Secondary Hyperparathyroidism

  2004cites this paper
• THE EFFECT OF VITAMIN D3 ON INSULIN SECRETION AND PERIPHERAL INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS

  2003cites this paper
• Gabapentin-induced hypoglycemia in a long-term peritoneal dialysis patient.

  2003cites this paper
• Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women

  2003cites this paper
• A moderately low phosphate intake may provide health benefits analogous to those conferred by UV light - a further advantage of vegan diets.

  2003cites this paper
• PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight.

  2003cites this paper
• Increased resistin blood levels are not associated with insulin resistance in patients with renal disease.

  2003cites this paper
• Derangement of glucose metabolism in hyperparathyroidism

  2003cites this paper
• Hypocalcemia reduces insulin turnover but not insulin-mediated glucose metabolism in piglets

  2002cites this paper
• Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT.

  2001cites this paper
• Intraperitoneal Versus Subcutaneous Insulin Treatment in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis Therapy

  2001cites this paper
• Less of insulin desensitization in sympathetic nerve terminals from wistar rats with insulin resistance.

  2000cites this paper
• Vitamin D: Actions for the new millennium

  2000cites this paper
• Insulin assays and reference values.

  1999cites this paper
• The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure.

  1999cites this paper